ASCO® 2024 Insights: "Genomic Alterations in HR+/HER2- Metastatic Breast Cancer - Co-Occurrence and Prevalence Across Treatment" | VuMedi

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time 0:00

This video is featured in the 2024 ASCO® Annual Meeting Insights Hub

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Genomic Alterations in HR+/HER2- Metastatic Breast Cancer - Co-Occurrence and Prevalence Across Treatment"

By 2024 ASCO® Annual Meeting Insights Hub FEATURING Manali Bhave

By 2024 ASCO® Annual Meeting Insights Hub FEATURING Manali Bhave

0 views

July 10, 2024

Comments 0

Login to view comments. Click here to Login